Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Chronic Heart Failure

  Free Subscription


Articles published in Am Heart J

Retrieve available abstracts of 86 articles:
HTML format
Text format



Single Articles


    August 2018
  1. COLIN-RAMIREZ E, Ezekowitz JA
    Rationale and design of the Study of Dietary Intervention Under 100 MMOL in Heart Failure (SODIUM-HF).
    Am Heart J. 2018;205:87-96.
    PubMed     Text format     Abstract available


  2. MACK MJ, Abraham WT, Lindenfeld J, Bolling SF, et al
    Cardiovascular Outcomes Assessment of the MitraClip in Patients with Heart Failure and Secondary Mitral Regurgitation: Design and rationale of the COAPT trial.
    Am Heart J. 2018;205:1-11.
    PubMed     Text format     Abstract available


    July 2018
  3. MILLER PE, Ahmad T
    Loop diuretics in heart failure: Few facts and lots of prejudice.
    Am Heart J. 2018 Jul 30. pii: S0002-8703(18)30234.
    PubMed     Text format    


  4. FUDIM M, Loungani R, Doerfler SM, Coles A, et al
    Worsening renal function during decongestion among patients hospitalized for heart failure: Findings from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) trial.
    Am Heart J. 2018;204:163-173.
    PubMed     Text format     Abstract available


  5. FUDIM M, O'Connor CM, Mulder H, Coles A, et al
    Loop diuretic adjustments in patients with chronic heart failure: Insights from HF-ACTION.
    Am Heart J. 2018 Jul 29. pii: S0002-8703(18)30233.
    PubMed     Text format     Abstract available


  6. MORICI N, Oliva F, Ajello S, Stucchi M, et al
    Management of cardiogenic shock in acute decompensated chronic heart failure: The ALTSHOCK phase II clinical trial.
    Am Heart J. 2018 Jul 20. pii: S0002-8703(18)30217.
    PubMed     Text format     Abstract available


  7. MENTZ RJ, O'Connor CM, Granger BB, Yang H, et al
    Palliative care and hospital readmissions in patients with advanced heart failure: Insights from the PAL-HF trial.
    Am Heart J. 2018 Jul 20. pii: S0002-8703(18)30219.
    PubMed     Text format    


  8. KETEYIAN SJ, Kerrigan DJ, Lewis B, Ehrman JK, et al
    Exercise training workloads in cardiac rehabilitation are associated with clinical outcomes in patients with heart failure.
    Am Heart J. 2018;204:76-82.
    PubMed     Text format     Abstract available


  9. KOROL S, White M, O'Meara E, Tournoux F, et al
    A comparison of the effects of selective and non-selective mineralocorticoid antagonism on glucose homeostasis of heart failure patients with glucose intolerance or type II diabetes: A randomized controlled double-blind trial.
    Am Heart J. 2018 Jul 10. pii: S0002-8703(18)30203.
    PubMed     Text format     Abstract available


  10. DAUBERT MA, Whellan DJ, Woehrle H, Tasissa G, et al
    Treatment of sleep-disordered breathing in heart failure impacts cardiac remodeling: Insights from the CAT-HF Trial.
    Am Heart J. 2018;201:40-48.
    PubMed     Text format     Abstract available


  11. UPADHYA B, Brubaker PH, Morgan TM, Eggebeen JD, et al
    The effect of Aliskiren on exercise capacity in older patients with heart failure and preserved ejection fraction: A randomized, placebo-controlled, double-blind trial.
    Am Heart J. 2018;201:164-167.
    PubMed     Text format     Abstract available


    June 2018
  12. ARNOLD SV, Echouffo-Tcheugui JB, Lam CS, Inzucchi SE, et al
    Patterns of glucose-lowering medication use in patients with type 2 diabetes and heart failure. Insights from the Diabetes Collaborative Registry (DCR).
    Am Heart J. 2018;203:25-29.
    PubMed     Text format     Abstract available


  13. BALLING L, Thomsen JH, Wolsk E, Hassager C, et al
    Hemodynamic effects of short-term infusion of a vasopressin V1A/V2 receptor antagonist conivaptan in patients with chronic heart failure during submaximal exercise.
    Am Heart J. 2018 Jun 14. pii: S0002-8703(18)30172.
    PubMed     Text format    


  14. AHMAD FS, French B, Bowles KH, Sevilla-Cazes J, et al
    Incorporating patient-centered factors into heart failure readmission risk prediction: A mixed-methods study.
    Am Heart J. 2018;200:75-82.
    PubMed     Text format     Abstract available


  15. LUO N, Ballew NG, O'Brien EC, Greiner MA, et al
    Early impact of guideline publication on angiotensin-receptor neprilysin inhibitor use among patients hospitalized for heart failure.
    Am Heart J. 2018;200:134-140.
    PubMed     Text format     Abstract available


  16. JALNAPURKAR S, Zhao X, Heidenreich PA, Bhatt DL, et al
    A Hospital Level Analysis of 30-Day Readmission Performance for Heart Failure Patients and Long-Term Survival: Findings from Get With The Guidelines-Heart Failure.
    Am Heart J. 2018;200:127-133.
    PubMed     Text format     Abstract available


    May 2018
  17. MCALISTER FA, Youngson E, van Diepen S, Ezekowitz JA, et al
    Influence of hospital volume on outcomes for patients with heart failure: Evidence from a Canadian national cohort study.
    Am Heart J. 2018 May 27. pii: S0002-8703(18)30164.
    PubMed     Text format     Abstract available


  18. SHAKIR M, Wasfy JH
    Heart failure and readmissions: Research in the public eye.
    Am Heart J. 2018;203:1-3.
    PubMed     Text format    


  19. WAGNER J, Agostoni P, Arena R, Belardinelli R, et al
    The Role of Gas Exchange Variables in Cardiopulmonary Exercise Testing for Risk Stratification and Management of Heart Failure with Reduced Ejection Fraction.
    Am Heart J. 2018;202:116-126.
    PubMed     Text format     Abstract available


  20. CAINZOS-ACHIRICA M, Rebordosa C, Vela E, Cleries M, et al
    Challenges of evaluating chronic heart failure and acute heart failure events in research studies using large health care databases.
    Am Heart J. 2018;202:76-83.
    PubMed     Text format     Abstract available


  21. LUK A, Groarke JD, Desai AS, Mahmood SS, et al
    First spot urine sodium after initial diuretic identifies patients at high risk for adverse outcome after heart failure hospitalization.
    Am Heart J. 2018 May 19. pii: S0002-8703(18)30152.
    PubMed     Text format     Abstract available


  22. AMBROSY AP, Bhatt AS, Stebbins AL, Wruck LM, et al
    Prevalent digoxin use and subsequent risk of death or hospitalization in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) ran
    Am Heart J. 2018;199:97-104.
    PubMed     Text format     Abstract available


  23. VAN SPALL HGC, Lee SF, Xie F, Ko DT, et al
    Knowledge to action: Rationale and design of the Patient-Centered Care Transitions in Heart Failure (PACT-HF) stepped wedge cluster randomized trial.
    Am Heart J. 2018;199:75-82.
    PubMed     Text format     Abstract available


  24. PICCINI JP, Connolly SJ, Abraham WT, Healey JS, et al
    A genotype-directed comparative effectiveness trial of Bucindolol and metoprolol succinate for prevention of symptomatic atrial fibrillation/atrial flutter in patients with heart failure: Rationale and design of the GENETIC-AF trial.
    Am Heart J. 2018;199:51-58.
    PubMed     Text format     Abstract available


  25. AMBROSY AP, Velazquez EJ
    Angiotensin receptor-neprilysin inhibitor therapy in heart failure: An end that justifies the means.
    Am Heart J. 2018;199:176-177.
    PubMed     Text format    


  26. JANUZZI JL, Butler J, Fombu E, Maisel A, et al
    Rationale and methods of the Prospective Study of Biomarkers, Symptom Improvement, and Ventricular Remodeling During Sacubitril/Valsartan Therapy for Heart Failure (PROVE-HF).
    Am Heart J. 2018;199:130-136.
    PubMed     Text format     Abstract available


  27. VETROVEC GW, Anderson M, Schreiber T, Popma J, et al
    The cVAD registry for percutaneous temporary hemodynamic support: A prospective registry of Impella mechanical circulatory support use in high-risk PCI, cardiogenic shock, and decompensated heart failure.
    Am Heart J. 2018;199:115-121.
    PubMed     Text format     Abstract available


  28. AJAM T, Ajam S, Devaraj S, Mohammed K, et al
    Effect of carvedilol vs metoprolol succinate on mortality in heart failure with reduced ejection fraction.
    Am Heart J. 2018;199:1-6.
    PubMed     Text format     Abstract available


    April 2018
  29. PENNY WF, Henry TD, Watkins MW, Patel AN, et al
    Design of a Phase 3 trial of intracoronary administration of human adenovirus 5 encoding human adenylyl cyclase type 6 (RT-100) gene transfer in patients with heart failure with reduced left ventricular ejection fraction: The FLOURISH Clinical Trial.
    Am Heart J. 2018;201:111-116.
    PubMed     Text format     Abstract available


  30. RAVAL AN, Cook TD, Duckers HJ, Johnston PV, et al
    The CardiAMP Heart Failure trial: A randomized controlled pivotal trial of high-dose autologous bone marrow mononuclear cells using the CardiAMP cell therapy system in patients with post-myocardial infarction heart failure: Trial rationale and study d
    Am Heart J. 2018;201:141-148.
    PubMed     Text format     Abstract available


  31. VELAZQUEZ EJ, Morrow DA, DeVore AD, Ambrosy AP, et al
    Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trial.
    Am Heart J. 2018;198:145-151.
    PubMed     Text format     Abstract available


  32. KHAZANIE P, Hellkamp AS, Fonarow GC, Curtis LH, et al
    Permanent pacemaker use among patients with heart failure and preserved ejection fraction: Findings from the Acute Decompensated Heart Failure National Registry (ADHERE) National Registry.
    Am Heart J. 2018;198:123-128.
    PubMed     Text format     Abstract available


    March 2018
  33. SULLIVAN LT 2ND, Randolph T, Merrill P, Jackson LR 2nd, et al
    Representation of black patients in randomized clinical trials of heart failure with reduced ejection fraction.
    Am Heart J. 2018;197:43-52.
    PubMed     Text format     Abstract available


    February 2018
  34. VAN BOVEN N, Battes LC, Akkerhuis KM, Rizopoulos D, et al
    Toward personalized risk assessment in patients with chronic heart failure: Detailed temporal patterns of NT-proBNP, troponin T, and CRP in the Bio-SHiFT study.
    Am Heart J. 2018;196:36-48.
    PubMed     Text format    


    January 2018
  35. MANGLA A, Doukky R, Richardson D, Avery EF, et al
    Design of a bilevel clinical trial targeting adherence in heart failure patients and their providers: The Congestive Heart Failure Adherence Redesign Trial (CHART).
    Am Heart J. 2018;195:139-150.
    PubMed     Text format     Abstract available


    December 2017
  36. DA ROSA PR, Rohde LE, Doebber M, Ribeiro ALP, et al
    Rational and design of a randomized, double-blind, multicenter trial to evaluate the safety and tolerability of furosemide withdrawal in stable chronic outpatients with heart failure: The ReBIC-1 trial.
    Am Heart J. 2017;194:125-131.
    PubMed     Text format     Abstract available


    November 2017
  37. SHADDY R, Canter C, Halnon N, Kochilas L, et al
    Design for the sacubitril/valsartan (LCZ696) compared with enalapril study of pediatric patients with heart failure due to systemic left ventricle systolic dysfunction (PANORAMA-HF study).
    Am Heart J. 2017;193:23-34.
    PubMed     Text format     Abstract available


    October 2017
  38. CERBIN LP, Ambrosy AP, Mentz RJ
    Building the case for aerobic exercise in ambulatory patients with heart failure and a reduced ejection fraction.
    Am Heart J. 2017;192:e3.
    PubMed     Text format    


  39. TAYLOR R, Dalal H, Davies R, Doherty P, et al
    Cardiac rehabilitation in heart failure with reduced ejection fraction: A "should take it and not leave it" intervention.
    Am Heart J. 2017;192:e1-e2.
    PubMed     Text format    


  40. GAGGIN HK, Chen-Tournoux AA, Christenson RH, Doros G, et al
    Rationale and design of the ICON-RELOADED study: International Collaborative of N-terminal pro-B-type Natriuretic Peptide Re-evaluation of Acute Diagnostic Cut-Offs in the Emergency Department.
    Am Heart J. 2017;192:26-37.
    PubMed     Text format     Abstract available


  41. ADIR Y, Guazzi M, Offer A, Temporelli PL, et al
    Pulmonary hemodynamics in heart failure patients with reduced or preserved ejection fraction and pulmonary hypertension: Similarities and disparities.
    Am Heart J. 2017;192:120-127.
    PubMed     Text format     Abstract available


    September 2017
  42. SHERWOOD A, Hill LK, Blumenthal JA, Adams KF Jr, et al
    Blood pressure reactivity to psychological stress is associated with clinical outcomes in patients with heart failure.
    Am Heart J. 2017;191:82-90.
    PubMed     Text format     Abstract available


  43. LUO N, Teng TK, Tay WT, Anand IS, et al
    Multinational and multiethnic variations in health-related quality of life in patients with chronic heart failure.
    Am Heart J. 2017;191:75-81.
    PubMed     Text format     Abstract available


  44. FRIEDMAN DJ, Al-Khatib SM, Zeitler EP, Han J, et al
    New York Heart Association class and the survival benefit from primary prevention implantable cardioverter defibrillators: A pooled analysis of 4 randomized controlled trials.
    Am Heart J. 2017;191:21-29.
    PubMed     Text format     Abstract available


    August 2017
  45. AUSTIN CO, Landolfo K, Parikh PP, Patel PC, et al
    Retained cardiac implantable electronic device fragments are not associated with magnetic resonance imaging safety issues, morbidity, or mortality after orthotopic heart transplant.
    Am Heart J. 2017;190:46-53.
    PubMed     Text format     Abstract available


  46. GIMPELEWICZ C, Metra M, Cleland JGF, Szecsody P, et al
    Effects of serelaxin on the outcome of patients with or without substantial peripheral edema: A subgroup analysis from the RELAX-AHF trial.
    Am Heart J. 2017;190:113-122.
    PubMed     Text format     Abstract available


    July 2017
  47. RANDOLPH TC, Hellkamp AS, Zeitler EP, Fonarow GC, et al
    Utilization of cardiac resynchronization therapy in eligible patients hospitalized for heart failure and its association with patient outcomes.
    Am Heart J. 2017;189:48-58.
    PubMed     Text format     Abstract available


  48. HARIKRISHNAN S, Sanjay G, Agarwal A, Kumar NP, et al
    One-year mortality outcomes and hospital readmissions of patients admitted with acute heart failure: Data from the Trivandrum Heart Failure Registry in Kerala, India.
    Am Heart J. 2017;189:193-199.
    PubMed     Text format     Abstract available


  49. DEVORE AD, Thomas L, Albert NM, Butler J, et al
    Change the management of patients with heart failure: Rationale and design of the CHAMP-HF registry.
    Am Heart J. 2017;189:177-183.
    PubMed     Text format     Abstract available


  50. CUNNINGHAM JW, Nathan AS, Rhodes J, Shafer K, et al
    Decline in peak oxygen consumption over time predicts death or transplantation in adults with a Fontan circulation.
    Am Heart J. 2017;189:184-192.
    PubMed     Text format     Abstract available


    June 2017
  51. TER MAATEN JM, Maggioni AP, Latini R, Masson S, et al
    Clinical and prognostic value of spot urinary creatinine in chronic heart failure-An analysis from GISSI-HF.
    Am Heart J. 2017;188:189-195.
    PubMed     Text format     Abstract available


  52. BRISCO-BACIK MA
    Prognostication on the spot! The evolving importance of urinary creatinine in heart failure.
    Am Heart J. 2017;188:186-188.
    PubMed     Text format    


  53. GOLDBERG SL, Meredith I, Marwick T, Haluska BA, et al
    A randomized double-blind trial of an interventional device treatment of functional mitral regurgitation in patients with symptomatic congestive heart failure-Trial design of the REDUCE FMR study.
    Am Heart J. 2017;188:167-174.
    PubMed     Text format     Abstract available


  54. RASLAN IR, Brown P, Westerhout CM, Ezekowitz JA, et al
    Characterization of hemodynamically stable acute heart failure patients requiring a critical care unit admission: Derivation, validation, and refinement of a risk score.
    Am Heart J. 2017;188:127-135.
    PubMed     Text format     Abstract available


  55. VUKADINOVIC D, Lavall D, Vukadinovic AN, Pitt B, et al
    True rate of mineralocorticoid receptor antagonists-related hyperkalemia in placebo-controlled trials: A meta-analysis.
    Am Heart J. 2017;188:99-108.
    PubMed     Text format     Abstract available


  56. MOGENSEN UM, Kober L, Kristensen SL, Jhund PS, et al
    The effects of sacubitril/valsartan on coronary outcomes in PARADIGM-HF.
    Am Heart J. 2017;188:35-41.
    PubMed     Text format     Abstract available


  57. JOHANSEN ND, Biering-Sorensen T, Jensen JS, Mogelvang R, et al
    Diastolic dysfunction revisited: A new, feasible, and unambiguous echocardiographic classification predicts major cardiovascular events.
    Am Heart J. 2017;188:136-146.
    PubMed     Text format     Abstract available


    May 2017
  58. PANG PS, Teerlink JR, Boer-Martins L, Gimpelewicz C, et al
    Day vs night: Does time of presentation matter in acute heart failure? A secondary analysis from the RELAX-AHF trial.
    Am Heart J. 2017;187:62-69.
    PubMed     Text format     Abstract available


    April 2017
  59. BAEZA-TRINIDAD R, Mosquera-Lozano JD
    Bendopnea: The next prognostic marker of advanced heart failure?
    Am Heart J. 2017;186:e1.
    PubMed     Text format    


  60. ECHOUFFO-TCHEUGUI JB, Bishu KG, Fonarow GC, Egede LE, et al
    Trends in health care expenditure among US adults with heart failure: The Medical Expenditure Panel Survey 2002-2011.
    Am Heart J. 2017;186:63-72.
    PubMed     Text format     Abstract available


  61. AMBROSY AP, Cerbin LP, DeVore AD, Greene SJ, et al
    Aerobic exercise training and general health status in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION)trial.
    Am Heart J. 2017;186:130-138.
    PubMed     Text format     Abstract available


  62. FLINT K
    Cardiac rehabilitation in heart failure with reduced ejection fraction: A "take it or leave it" intervention.
    Am Heart J. 2017;186:127-129.
    PubMed     Text format    


    March 2017
  63. KUPSKY DF, Ahmed AM, Sakr S, Qureshi WT, et al
    Cardiorespiratory fitness and incident heart failure: The Henry Ford ExercIse Testing (FIT) Project.
    Am Heart J. 2017;185:35-42.
    PubMed     Text format     Abstract available


  64. REEVES GR, Whellan DJ, Duncan P, O'Connor CM, et al
    Rehabilitation Therapy in Older Acute Heart Failure Patients (REHAB-HF) trial: Design and rationale.
    Am Heart J. 2017;185:130-139.
    PubMed     Text format     Abstract available


  65. CHAMBERLAIN AM, Alonso A, Gersh BJ, Manemann SM, et al
    Multimorbidity and the risk of hospitalization and death in atrial fibrillation: A population-based study.
    Am Heart J. 2017;185:74-84.
    PubMed     Text format     Abstract available


  66. ROBINSON VM, Bharucha DB, Mahaffey KW, Dorian P, et al
    Results of a curtailed randomized controlled trial, evaluating the efficacy and safety of azimilide in patients with implantable cardioverter-defibrillators: The SHIELD-2 trial.
    Am Heart J. 2017;185:43-51.
    PubMed     Text format     Abstract available


  67. BARRIOS D, Morillo R, Lobo JL, Nieto R, et al
    Assessment of right ventricular function in acute pulmonary embolism.
    Am Heart J. 2017;185:123-129.
    PubMed     Text format     Abstract available


  68. HORNE BD, Budge D, Masica AL, Savitz LA, et al
    Early inpatient calculation of laboratory-based 30-day readmission risk scores empowers clinical risk modification during index hospitalization.
    Am Heart J. 2017;185:101-109.
    PubMed     Text format     Abstract available


  69. RICCI F, Mele D, Bianco F, Bucciarelli V, et al
    Right heart-pulmonary circulation unit and cardiac resynchronization therapy.
    Am Heart J. 2017;185:1-16.
    PubMed     Text format     Abstract available


    February 2017
  70. KHAN H, Jaffar N, Rauramaa R, Kurl S, et al
    Cardiorespiratory fitness and nonfatalcardiovascular events: A population-based follow-up study.
    Am Heart J. 2017;184:55-61.
    PubMed     Text format     Abstract available


    January 2017
  71. VERMA AK, Schulte PJ, Bittner V, Keteyian SJ, et al
    Socioeconomic and partner status in chronic heart failure: Relationship to exercise capacity, quality of life, and clinical outcomes.
    Am Heart J. 2017;183:54-61.
    PubMed     Text format     Abstract available


  72. COX ZL, Lewis CM, Lai P, Lenihan DJ, et al
    Validation of an automated electronic algorithm and "dashboard" to identify and characterize decompensated heart failure admissions across a medical center.
    Am Heart J. 2017;183:40-48.
    PubMed     Text format     Abstract available


  73. NAGARAJAN V, Hernandez AV, Cauthen CA, Starling RC, et al
    Usefulness of cell-mediated immune function in risk stratification for patients with advanced heart failure.
    Am Heart J. 2017;183:35-39.
    PubMed     Text format     Abstract available


  74. STEINHAUS DA, Mostofsky E, Levitan EB, Dorans KS, et al
    Chocolate intake and incidence of heart failure: Findings from the Cohort of Swedish Men.
    Am Heart J. 2017;183:18-23.
    PubMed     Text format     Abstract available


  75. THIBODEAU JT, Jenny BE, Maduka JO, Divanji PH, et al
    Bendopnea and risk of adverse clinical outcomes in ambulatory patients with systolic heart failure.
    Am Heart J. 2017;183:102-107.
    PubMed     Text format     Abstract available


    December 2016
  76. ECHOUFFO-TCHEUGUI JB, Xu H, DeVore AD, Schulte PJ, et al
    Temporal trends and factors associated with diabetes mellitus among patients hospitalized with heart failure: Findings from Get With The Guidelines-Heart Failure registry.
    Am Heart J. 2016;182:9-20.
    PubMed     Text format     Abstract available


  77. SPITZER E, Van Mieghem NM, Pibarot P, Hahn RT, et al
    Rationale and design of the Transcatheter Aortic Valve Replacement to UNload the Left ventricle in patients with ADvanced heart failure (TAVR UNLOAD) trial.
    Am Heart J. 2016;182:80-88.
    PubMed     Text format     Abstract available


    November 2016
  78. LEE DS, Lee JS, Schull MJ, Grimshaw JM, et al
    Design and rationale for the Acute Congestive Heart Failure Urgent Care Evaluation: The ACUTE Study.
    Am Heart J. 2016;181:60-65.
    PubMed     Text format     Abstract available


  79. PROIETTI M, Laroche C, Drozd M, Vijgen J, et al
    Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.
    Am Heart J. 2016;181:83-91.
    PubMed     Text format     Abstract available


    September 2016
  80. MCNEELY C, Markwell S, Vassileva CM
    Readmission after inpatient percutaneous coronary intervention in the Medicare population from 2000 to 2012.
    Am Heart J. 2016;179:195-203.
    PubMed     Text format     Abstract available


  81. BUCK J, Kaboli P, Gage BF, Cram P, et al
    Trends in antithrombotic therapy for atrial fibrillation: Data from the Veterans Health Administration Health System.
    Am Heart J. 2016;179:186-91.
    PubMed     Text format     Abstract available


  82. MARSO SP, McGuire DK, Zinman B, Poulter NR, et al
    Design of DEVOTE (Trial Comparing Cardiovascular Safety of Insulin Degludec vs Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events) - DEVOTE 1.
    Am Heart J. 2016;179:175-83.
    PubMed     Text format     Abstract available


  83. SHAH R, Hellkamp A, Lokhnygina Y, Becker RC, et al
    Use of concomitant aspirin in patients with atrial fibrillation: Findings from the ROCKET AF trial.
    Am Heart J. 2016;179:77-86.
    PubMed     Text format     Abstract available


    July 2016
  84. PEGUERO JG, Lo Presti S, Issa O, Podesta C, et al
    Simplified prediction of postoperative cardiac surgery outcomes with a novel score: R2CHADS2.
    Am Heart J. 2016;177:153-9.
    PubMed     Text format     Abstract available


  85. KIM EJ, Yin X, Fontes JD, Magnani JW, et al
    Atrial fibrillation without comorbidities: Prevalence, incidence and prognosis (from the Framingham Heart Study).
    Am Heart J. 2016;177:138-44.
    PubMed     Text format     Abstract available


  86. BAKKESTROM R, Larsen LA, Moller JE, Videbaek L, et al
    Mitral valve regurgitation in twins: Concordance and survival.
    Am Heart J. 2016;177:51-7.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: